MTOR and breast cancer: Mechanistically, hypermethylation‐mediated SALL2 reduction induced anti‐estrogen resistance by downregulating ERα and promoted hormone‐independent growth by regulation of PTEN/Akt/mTOR signaling cascade in human breast cancer cells.